Short-term outcome of chronic immunosuppression on the development of breast lesions in premenopausal heart and lung transplant patients

Journal of Surgical Research

Volumn 78, Issue 1, 1998, Pages 27-30

  Campbell, Anne ^a   Moazami, Nader ^a   Ditkoff, Beth Ann ^a   Kurtz, Ellen ^a   Estabrook, Alison ^a   Schnabel, Freya ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

Benign breast disease; Fibroadenoma; Immunosuppression; Thoracic transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; STEROID;

ADOLESCENT; ADULT; ARTICLE; BREAST FIBROADENOMA; BREAST LESION; CHILD; CYSTOSARCOMA PHYLLOIDES; FIBROCYSTIC BREAST DISEASE; FOLLOW UP; GRAFT REJECTION; HEART LUNG TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL;

EID: 0032527356     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5414     Document Type: Article

References (15)

1. Stewart, T., Tsai, J., Grayson, H., et al. Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet 346: 796-798, 1995.
2. Baildam, A. D., Higgins, R. M., Hurley, E., et al. Cyclosporin A and multiple fibroadenomas of the breast. Br. J. Surg. 83: 1755-1757, 1996.
3. Penn, I. Cancers following cyclosporine therapy. Transplantation 43: 32-35, 1987.
4. Penn, I. Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 83: 492-499, 1978.
5. Penn, I., and Brunson, M. E. Cancers after cyclosporine therapy. Transplant. Proc. 20: 885-892, 1988.
6. Penn, I. Cancers complicating organ transplantation. N. Engl. J. Med. 323: 1767-1769, 1990.
7. Penn, I. The changing pattern of posttransplant malignancies. Transplant. Proc. 23: 1101-1103, 1991.
8. Opelz, G., and Henderson, R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342: 1514-1516, 1993.
9. Wilkinson, A. H., Smith, J. L., Hunsicker, L. G., et al. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation 47: 293-296, 1989.
10. Swinnen, L. J., Costanzo-Nordin, M. R., Fisher, S. G., et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant patients. N. Engl. J. Med. 323: 1723-1728, 1990.
11. Morrison, V. A., Dunn, D. L., Manivel, J. C., et al. Clinical characteristics of post-transplant lymphoproliferative disorders. Am. J. Med. 97: 14-24, 1994.
12. Leblond, V., Sutton, L., Dorent, R. et al. Lymphoproliferative disorders after organ transplantation: A report of 24 cases observed in a single center. J. Clin. Onc. 13: 961-968, 1995.
13. Hanson, M. N., Morrison, V. A., Peterson, B. A., et al. Posttransplant T-cell lymphoproliferative disorders - An aggressive, late complication of solid organ transplantation. Blood 88: 3626-3633, 1996.
14. Frantz, V. K., Pickren, J. W., Melcher, G. W., et al. Incidence of chronic cystic disease in so-called "normal breasts": A study based on 225 postmortem examinations. Cancer 40: 762-783, 1951.
15. Houlihan, M. J. Fibroadenoma and hamartoma. In Diseases of the Breast (J. R. Harris, M. E. Lipmann, M. Morrow, S. Hellman, Eds.), Philadelphia: Lippincott-Raven, 1996.